Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > 99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - large image1
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image1
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image2
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image3
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image4
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image5
99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide buy - image6

99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide

7020 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

tianjin

Brand:

tengchu

Packaging:

5mg/box,10mg/box

Price valid (until):

2024-07-05

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

ghk-cu,Semaglutide,tirzepatide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Contact me 

    Email: tengchu03@zhuanjinbio.com

    whatsapp:+852 9444 5081


    Shop 99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide-Detailed Image 1 Shop 99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide-Detailed Image 2

    Shop 99% Retatrutide Powder CAS 2381089-83-2 GLP-1 GIP GCGR Receptors Peptide-Detailed Image 3

    Specification 

    What is Retatrutide?
    Retatrutide is the newest GLP-1R agonist and was approved by the FDA as a once-weekly injection for the treatment of T2DM in late 2017. The peptide is chemically similar to semaglutide,tirzepatide, with the inclusion of two structural modifications (Lau, Bloch, et al., 2015). The first is the replacement of Gly with the non-proteinogenic amino acid 2-aminoisobutyric acid (Aib) at position 2. The second is the attachment of octadecanoic diacid to the side chain of Lys-26 through a short polyethylene glycol (PEG) spacer and a γ-glutamic acid linker. The amino acid substitution renders the peptide more resistant to DPP-4 compared to liraglutide, and the presence of the 18-carbon fatty acid moiety results in a high binding affinity for serum albumin, which translates to a half-life of approximately 7 days in humans.

    Product Name Retatrutide
    Purity ≥99%
    Colour White Powder
    CAS NO. 2381089-83-2
    EINECS NO. 200-001-8
    Storage Store in cool and dry places, keep away from strong light.

     

       Company profile

     


    Qingdao Xinli Technology Development Co., Ltd.address is in Qingdao, and the service is good.      Our customers come from different countries, such as the United States, Europe, Japan, Korea, India and so on.       The company is committed to the separation, purification and chiral separation of high purity natural products, as well as the development, production and marketing of API intermediates.    The company mainly engaged in high-end monomer products of natural medicinal plants, semi-synthetic derivatives of medicinal plant ingredients, chemical synthetic products, high-end natural food and cosmetic additives.    The company is a research and development and innovation as one of the high-tech Co., LTD.      Years of technology research and development, with excellent design concept to meet customer needs, to provide customers with differentiated products.


    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 5
    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 6



     

      FAQ


    Q:Can we print our logo on the product?

    A:Of course, we can do it. Just send us your logo design.


    Q:How about the price? Can you make it cheaper?

    A:We always take the customer's benefit as the top priority. Price is negotiable under different conditions, we are assuring you to get the most competitive price.


    Q:Do you offer free samples?

    A:A 5Stars Review=A Free Sample It's appreciated that you could write us positive reviews if you like our products and service, we will offer you some free samples on your next order.


    Q:How Can I place an order?

    A:You could directly place an order via Alibaba, and sure you could just send us inquiry to any of our sales representatives to get detailed order information, and we will explain' the detail process.


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    ghk-cu,Semaglutide,tirzepatide,Retatrutide

    Location:

    Room 68-5-501, Lianqiang Residential Area, No. 371 Union Road, Union Street, Xinhua District, Shijiazhuang City, Hebei Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2022

  • Inquiry History
    7020 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.